Prediction of fast decline in amyloid positive mild cognitive impairment patients using multimodal biomarkers

It may be possible to classify patients with Aβ positive (+) mild cognitive impairment (MCI) into fast and slow decliners according to their biomarker status. In this study, we aimed to develop a risk prediction model to predict fast decline in the Aβ+ MCI population using multimodal biomarkers. We...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuroimage Clin
Egile Nagusiak: Jang, Hyemin, Park, Jongyun, Woo, Sookyoung, Kim, Seonwoo, Kim, Hee Jin, Na, Duk L., Lockhart, Samuel N., Kim, Yeshin, Kim, Ko Woon, Cho, Soo Hyun, Kim, Seung Joo, Seong, Joon-Kyung, Seo, Sang Won
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2019
Gaiak:
Regular Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6677900/
https://ncbi.nlm.nih.gov/pubmed/31376643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nicl.2019.101941
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak